|
GB0428166D0
|
|
Use of essentially fatty acid molecules
|
|
US5324748A
|
|
Method for enhancement of 1-series PG production
|
|
US5246726A
|
|
Iron-containing composition and method for treatment of cancer
|
|
US5145686A
|
|
Topical pharmaceutical compositions
|
|
US5262174A
|
|
Anti-viral compositions
|
|
GB8729153D0
|
|
Fatty acid compositions
|
|
GB8725804D0
|
|
Treatment of male pattern baldness
|
|
GB8720984D0
|
|
Treatment of male pattern baldness
|
|
GB8719988D0
|
|
Chemical compounds
|
|
EP0257939A2
|
|
Platinum derivatives and cancer treatments
|
|
GB8716436D0
|
|
Gamma-linolenic acid
|
|
GB8715914D0
|
|
Treatment of cerabral disorders
|
|
GB8714772D0
|
|
Essential fatty acid compositions
|
|
GB8713026D0
|
|
Fatty acid composition
|
|
GB8710656D0
|
|
Therapeutic composition
|
|
GB8709892D0
|
|
Virucidal compositions
|
|
GB8705459D0
|
|
Treatment of peptic ulcers
|
|
GB8621816D0
|
|
Therapeutic composition
|
|
ZA8604779B
|
|
Pharmaceutical and dietary composition
|
|
GB8607137D0
|
|
Compositions
|
